Sun.Oct 06, 2024

article thumbnail

Arm Position and Blood Pressure Readings

JAMA Internal Medicine

This crossover randomized clinical trial aims to determine the effect of different arm positions on blood pressure readings.

article thumbnail

Mendaera's $73m raise heads digital financings

pharmaphorum

Recent financings in the digital health sector include a $73 million round for artificial intelligence-enabled robotics player Mendaera, with Qure.ai, VieCure, Rippl, and Univa Health also raising money.Silicon Valley startup Mendaera has earmarked the Series B funding to complete the development of its handheld robotics, medical imaging and AI platform, which is intended for use in commonplace medical procedures like taking biopsies, organ and vascular access, and pain management.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists

JAMA Internal Medicine

This randomized clinical trial examines the effect of a benzodiazepine taper plus augmented cognitive behavioral therapy for insomnia program vs an unmasked taper plus standard cognitive behavioral therapy for insomnia.

article thumbnail

Activist investor Starboard builds $1bn Pfizer stake

pharmaphorum

Activist investor Starboard Value has amassed a $1bn stake in pharma group Pfizer and wants strategic changes to restore growth

64
article thumbnail

How to Turn “Check-the-Box” Compliance Trainings Into Real Learning

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.

article thumbnail

Drug Patent Expirations for the Week of October 6, 2024

Drug Patent Watch

NUCYNTA ER (tapentadol hydrochloride) Collegium pharm inc Patent: 8,114,383 Expiration: Oct 10, 2024 See More … Source

Drugs 52